BCTX
Briacell Therapeutics
BCTX
BCTX
25 hedge funds and large institutions have $379K invested in Briacell Therapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
+4
Holders Change %
+19.05%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
6
Reduced
6
Closed
4
Calls
$90K
Puts
$3K
Net Calls
+$87K
Net Calls Change
-$70K
Top Buyers
| 1 |
CF
Cantor Fitzgerald
New York
|
$31.6K |
| 2 |
VF
Virtu Financial
New York
|
$27K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$22.4K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$28.6K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
$62.2K |
